| Ticker Symbol | Entity Name | As Of Date | Company Name | Followers | Employees on Linkedin | Link | Industry | Date Added | Date Updated | Description | Website | Specialities | Logo | HQ.Street | HQ.City | HQ.State | HQ.Country | HQ.Postal | Headcount change in past 24 months | Company Name | Sector | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| nasdaq:blph | 3794518 | Apr 21st, 2024 12:00AM | Bellerophon Therapeutics | 1.5K | 13.00 | Open | Apr 20th, 2024 11:02PM | Apr 20th, 2024 11:02PM | Bellerophon Therapeutics is a clinical-stage biotherapeutics company focused on developing innovative products combining novel drugs and devices in the treatment of cardiopulmonary and cardiac diseases. Our mission is to develop well-studied molecules deployed through innovative delivery systems to treat diseases with significant unmet clinical need. | Open | Open | 184 Liberty Corner Rd | Warren | New Jersey | US | 07059 | Bellerophon Therapeutics | Health Care | Pharmaceuticals & Biotechnology | |||
| nasdaq:blph | 3794518 | Apr 20th, 2024 12:00AM | Bellerophon Therapeutics | 1.5K | 13.00 | Open | Apr 19th, 2024 11:02PM | Apr 20th, 2024 04:39PM | Bellerophon Therapeutics is a clinical-stage biotherapeutics company focused on developing innovative products combining novel drugs and devices in the treatment of cardiopulmonary and cardiac diseases. Our mission is to develop well-studied molecules deployed through innovative delivery systems to treat diseases with significant unmet clinical need. | Open | Open | 184 Liberty Corner Rd | Warren | New Jersey | US | 07059 | Bellerophon Therapeutics | Health Care | Pharmaceuticals & Biotechnology | |||
| nasdaq:blph | 3794518 | Apr 19th, 2024 12:00AM | Bellerophon Therapeutics | 1.5K | 13.00 | Open | Apr 18th, 2024 11:11PM | Apr 18th, 2024 11:11PM | Bellerophon Therapeutics is a clinical-stage biotherapeutics company focused on developing innovative products combining novel drugs and devices in the treatment of cardiopulmonary and cardiac diseases. Our mission is to develop well-studied molecules deployed through innovative delivery systems to treat diseases with significant unmet clinical need. | Open | Open | 184 Liberty Corner Rd | Warren | New Jersey | US | 07059 | Bellerophon Therapeutics | Health Care | Pharmaceuticals & Biotechnology | |||
| nasdaq:blph | 3794518 | Apr 18th, 2024 12:00AM | Bellerophon Therapeutics | 1.5K | 13.00 | Open | Apr 17th, 2024 11:07PM | Apr 18th, 2024 05:59PM | Bellerophon Therapeutics is a clinical-stage biotherapeutics company focused on developing innovative products combining novel drugs and devices in the treatment of cardiopulmonary and cardiac diseases. Our mission is to develop well-studied molecules deployed through innovative delivery systems to treat diseases with significant unmet clinical need. | Open | Open | 184 Liberty Corner Rd | Warren | New Jersey | US | 07059 | Bellerophon Therapeutics | Health Care | Pharmaceuticals & Biotechnology | |||
| nasdaq:blph | 3794518 | Apr 17th, 2024 12:00AM | Bellerophon Therapeutics | 1.5K | 13.00 | Open | Apr 16th, 2024 10:57PM | Apr 17th, 2024 02:23PM | Bellerophon Therapeutics is a clinical-stage biotherapeutics company focused on developing innovative products combining novel drugs and devices in the treatment of cardiopulmonary and cardiac diseases. Our mission is to develop well-studied molecules deployed through innovative delivery systems to treat diseases with significant unmet clinical need. | Open | Open | 184 Liberty Corner Rd | Warren | New Jersey | US | 07059 | Bellerophon Therapeutics | Health Care | Pharmaceuticals & Biotechnology | |||
| nasdaq:blph | 3794518 | Apr 16th, 2024 12:00AM | Bellerophon Therapeutics | 1.5K | 13.00 | Open | Apr 15th, 2024 10:49PM | Apr 16th, 2024 10:40AM | Bellerophon Therapeutics is a clinical-stage biotherapeutics company focused on developing innovative products combining novel drugs and devices in the treatment of cardiopulmonary and cardiac diseases. Our mission is to develop well-studied molecules deployed through innovative delivery systems to treat diseases with significant unmet clinical need. | Open | Open | 184 Liberty Corner Rd | Warren | New Jersey | US | 07059 | Bellerophon Therapeutics | Health Care | Pharmaceuticals & Biotechnology | |||
| nasdaq:blph | 3794518 | Apr 15th, 2024 12:00AM | Bellerophon Therapeutics | 1.5K | 13.00 | Open | Apr 14th, 2024 10:50PM | Apr 15th, 2024 04:21PM | Bellerophon Therapeutics is a clinical-stage biotherapeutics company focused on developing innovative products combining novel drugs and devices in the treatment of cardiopulmonary and cardiac diseases. Our mission is to develop well-studied molecules deployed through innovative delivery systems to treat diseases with significant unmet clinical need. | Open | Open | 184 Liberty Corner Rd | Warren | New Jersey | US | 07059 | Bellerophon Therapeutics | Health Care | Pharmaceuticals & Biotechnology | |||
| nasdaq:blph | 3794518 | Apr 14th, 2024 12:00AM | Bellerophon Therapeutics | 1.5K | 13.00 | Open | Apr 13th, 2024 10:42PM | Apr 14th, 2024 10:40AM | Bellerophon Therapeutics is a clinical-stage biotherapeutics company focused on developing innovative products combining novel drugs and devices in the treatment of cardiopulmonary and cardiac diseases. Our mission is to develop well-studied molecules deployed through innovative delivery systems to treat diseases with significant unmet clinical need. | Open | Open | 184 Liberty Corner Rd | Warren | New Jersey | US | 07059 | Bellerophon Therapeutics | Health Care | Pharmaceuticals & Biotechnology | |||
| nasdaq:blph | 3794518 | Apr 13th, 2024 12:00AM | Bellerophon Therapeutics | 1.5K | 13.00 | Open | Apr 12th, 2024 10:32PM | Apr 13th, 2024 11:07AM | Bellerophon Therapeutics is a clinical-stage biotherapeutics company focused on developing innovative products combining novel drugs and devices in the treatment of cardiopulmonary and cardiac diseases. Our mission is to develop well-studied molecules deployed through innovative delivery systems to treat diseases with significant unmet clinical need. | Open | Open | 184 Liberty Corner Rd | Warren | New Jersey | US | 07059 | Bellerophon Therapeutics | Health Care | Pharmaceuticals & Biotechnology | |||
| nasdaq:blph | 3794518 | Apr 12th, 2024 12:00AM | Bellerophon Therapeutics | 1.5K | 13.00 | Open | Apr 11th, 2024 10:36PM | Apr 12th, 2024 08:03AM | Bellerophon Therapeutics is a clinical-stage biotherapeutics company focused on developing innovative products combining novel drugs and devices in the treatment of cardiopulmonary and cardiac diseases. Our mission is to develop well-studied molecules deployed through innovative delivery systems to treat diseases with significant unmet clinical need. | Open | Open | 184 Liberty Corner Rd | Warren | New Jersey | US | 07059 | Bellerophon Therapeutics | Health Care | Pharmaceuticals & Biotechnology |